Zentiva to acquire CEE pharma business of Alvogen
Czech drugmaker Zentiva has announced it will buy the Central and Eastern European business of Alvogen, for an undisclosed amount. Alvogen CEE... Read More
Insighht on USFDA approval of Trikafta
Vertex Pharmaceuticals received approval from the U.S. Food and Drug Administration (FDA). This is a landmark approval where Vertex’s Trikafta earned this... Read More
How much is the average ideal royalty rate in pharmaceutical and biopharmaceutical business deal?
Posted on25 Oct 2019
Comments0
Here you can review the average royalty rate for the pharmaceutical and biopharmaceutical business deal. Click here to view the Royalty Chart... Read More
Pharma Licensing: Explore differences between Royalty rate & Royalty base
Posted on25 Oct 2019
Comments0
Royalty rate : The appropriate royalty rate depends on numerous factors including the relative bargaining strength of the licensor and the licensee,... Read More
Takeda Divesting Select OTC and Non-core Assets of takeda to Acino
Posted on25 Oct 2019
Tagsdisinvestment in pharma business, divestiment in pharma, Divestment in pharma, Takeda, Takeda acquires shire
Comments0
Takeda Pharmaceutical Company Limited announced that it has entered into an agreement to divest a portfolio of select over-the-counter (OTC) and prescription... Read More
GSK to disinvest Rabipur and Encepur – vaccine for USD 1.1 billion
Posted on22 Oct 2019
Comments0
GlaxoSmithKline (GSK) will sell two travel vaccines to Bavarian Nordic for up to 955 million euros ($1.1 billion), the British firm said... Read More
S. Korea’s Mediforum acquires local pharma firms C-TRI, i-World Pharm
South Korean bio-pharma company Mediforum Co. has acquired two local pharmaceutical firms C-TRI and i-World, a move that is expected to help... Read More
US FDA issued warning letter to Glenmark for Baddi plant
Posted on21 Oct 2019
Comments0
The US Food and Drug Administration has issued a warning letter to Glenmark Pharmaceutical Ltd’s manufacturing plant in Baddi, Himachal Pradesh, the company said... Read More
Alexion acquisition of Achillion: A 1 Billion Pharma Strategic Deal
Posted on21 Oct 2019
TagsAchillion, acquisition in pharma, Alexion Pharmaceuticals, global pharma deals, pharma deal, pharma strategic deal
Comments0
Achillion focuses on the development of oral small-molecule Factor D inhibitors to treat people with rare diseases affecting the ‘complement system’, such... Read More
New Drug Approval Case Study: USFDA approval of Galderma’s Aklief cream
US Food and Drug Administration (FDA) approved Galderma’s Aklief (trifarotene) cream, 0.005% for the topical treatment of acne. Aklief Cream is the... Read More